Trial Profile
A study evaluating compliance of FSME-Immune® and Encepur®
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2018
Price :
$35
*
At a glance
- Drugs Tick-borne encephalitis vaccine (Primary) ; Tick-borne encephalitis vaccine (Primary)
- Indications Encephalitis
- Focus Therapeutic Use
- 29 Mar 2018 New trial record